The biopharmaceutical industry has entered an era of unprecedented change and challenge, characterized by increasing pricing pressures, rising rates of attrition in the product development lifecycle, and decreasing scientific innovation. The most successful products are losing patent protection, and pipelines have been unable to fill the gap. This

chapter 1|12 pages

Redefining innovation

ByJeffrey S. Handen

chapter 2|20 pages

Collaborations of the future

ByMelinda S. Shockley

chapter 4|16 pages

Funding and resourcing clinical development

ByMichael A. Martorelli

chapter 5|22 pages

Emerging role of patients in clinical research

ByMichael S. Katz

chapter 6|18 pages

Innovative organizations: Viewpoints of organizational scholars and practitioners

ByLindsey Kotrba, Ia Ko, Daniel R. Denison

chapter 7|28 pages

Moving toward personalized medicine: How to transform product development

ByMichele Pontinen, Jian Wang, Christopher Bouton